Two Steps Forward for Biosimilars in the US: The Approval of Interchangeable Semglee®

First US Interchangeable Biosimilar Approved

The FDA’s Unique Biosimilar Regulatory Pathway

Increase Understanding to Improve Uptake

Insulin Biosimilars to Alleviate Spiraling Treatment Costs

Future of Development?